CLINICAL_TRIALS
trial_result
· 2014-10-15
Clinical Trial Update: Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease [Phase 4]
Summary
Phase 4 trial results posted for rasagiline as an add-on therapy to dopamine agonists in Parkinson's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Neuroscience, Inc. | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-10-15